Admission Values of IL-1β, IL-1Ra, and IL-1sRII in Plasma and CSF
| . | Group A . | Group B . | Group C . |
|---|---|---|---|
| . | Meningitis Without Shock . | Meningitis With Shock . | Shock Without Meningitis . |
| IL-1β | |||
| Plasma concentration, pg/mL | 55 (<40-135) | 70 (<40-250) | 140† (<40-2,500) |
| CSF concentration, pg/mL | 1,750 (<400-2,850) | 490 (65-3,150) | 67.5‡ (<40-1,550) |
| IL-1Ra | |||
| Plasma concentration, pg/mL | 6,750 (2,000-30,000) | 10,600 (5,100-390,000) | 145,000‡ρ (6,480-805,000) |
| CSF concentration, pg/mL | 26,500 (920-140,000) | 5,500 (<600-140,000) | 1,800* (<600-6,800) |
| Soluble IL-1RII | |||
| Plasma concentration, ng/mL | 23.9 (17.9-57.9) | 29.5 (18-57.1) | 22.7 (15.8-51.2) |
| CSF concentration, ng/mL | 36.3 (7.0-160.4) | 9.1 (<2.5-58.0) | 3.1‡ (<2.5-3.8) |
| . | Group A . | Group B . | Group C . |
|---|---|---|---|
| . | Meningitis Without Shock . | Meningitis With Shock . | Shock Without Meningitis . |
| IL-1β | |||
| Plasma concentration, pg/mL | 55 (<40-135) | 70 (<40-250) | 140† (<40-2,500) |
| CSF concentration, pg/mL | 1,750 (<400-2,850) | 490 (65-3,150) | 67.5‡ (<40-1,550) |
| IL-1Ra | |||
| Plasma concentration, pg/mL | 6,750 (2,000-30,000) | 10,600 (5,100-390,000) | 145,000‡ρ (6,480-805,000) |
| CSF concentration, pg/mL | 26,500 (920-140,000) | 5,500 (<600-140,000) | 1,800* (<600-6,800) |
| Soluble IL-1RII | |||
| Plasma concentration, ng/mL | 23.9 (17.9-57.9) | 29.5 (18-57.1) | 22.7 (15.8-51.2) |
| CSF concentration, ng/mL | 36.3 (7.0-160.4) | 9.1 (<2.5-58.0) | 3.1‡ (<2.5-3.8) |